Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-02 Sale | 2023-06-05 4:15 pm | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 5,000 | $8 | $40,000 | 739,118 (Direct) | View |
| 2023-05-01 Sale | 2023-05-03 4:05 pm | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 5,000 | $8 | $40,000 | 744,118 (Direct) | View |
| 2023-04-06 Sale | 2023-04-10 4:05 pm | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 5,000 | $8 | $40,000 | 749,118 (Direct) | View |
| 2023-03-17 Sale | 2023-03-20 4:05 pm | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 10,000 | $8 | $80,000 | 754,118 (Direct) | View |
| 2023-02-27 Purchase | 2023-02-27 5:20 pm | Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. AFEYAN NOUBAR 10% Owner | 3,323,310 | $5.78 | $19,208,732 | 21,716,886 (Indirect) | View |
| 2023-01-10 Sale | 2023-01-11 4:14 pm | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 20,000 | $8 | $160,000 | 764,118 (Direct) | View |
| 2022-09-14 Sale | 2022-09-15 4:10 pm | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 10,000 | $8 | $80,000 | 784,118 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-07 Option Award | 2024-02-09 5:14 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 5:00 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO | 523,877 | $0 | 523,877 (Direct) | View |
| 2023-07-10 Option Award(A) | 2024-02-09 5:00 pm | N/A 2033-07-09 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 36,713 | $0 | 36,713 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:59 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | Moore Yan Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:57 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | Reed Joshua Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:57 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 512,848 | $0 | 512,848 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:56 pm | N/A 2034-02-06 | Omega Therapeutics Inc. | OMGA | Zeng Ling See Remarks | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-08-28 Option Award | 2023-08-29 4:32 pm | N/A 2033-08-27 | Omega Therapeutics Inc. | OMGA | Werner Michelle C Director | 36,713 | $0 | 36,713 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 4:21 pm | N/A 2023-07-09 | Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director | 36,713 | $0 | 36,713 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | Boehm Rainer J. Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | BESHAR LUKE M Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | AFEYAN NOUBAR Director 10% Owner | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | Young Richard A Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | Levy Elliott M. Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:05 pm | N/A 2033-02-27 | Omega Therapeutics Inc. | OMGA | Moore Yan Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:05 pm | N/A 2033-02-27 | Omega Therapeutics Inc. | OMGA | McManus Kevin Chief Human Resources Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:05 pm | N/A 2033-02-27 | Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO | 170,000 | $0 | 170,000 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:05 pm | N/A 2033-02-27 | Omega Therapeutics Inc. | OMGA | Zeng Ling See Remarks | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:05 pm | N/A 2033-02-27 | Omega Therapeutics Inc. | OMGA | Reed Joshua Chief Financial Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:05 pm | N/A 2033-02-27 | Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer | 55,000 | $0 | 55,000 (Direct) | View |
Ownership | 2023-02-27 5:20 pm | N/A N/A | Omega Therapeutics Inc. | OMGA | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner | 0 | $0 | 1,329,324 (Indirect) | View |
| 2022-10-27 Option Award | 2022-10-28 6:43 pm | N/A 2032-10-26 | Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-28 6:40 pm | N/A 2032-10-26 | Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-28 6:39 pm | N/A 2032-10-26 | Omega Therapeutics Inc. | OMGA | Zeng Ling See Remarks | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-28 6:39 pm | N/A 2032-10-26 | Omega Therapeutics Inc. | OMGA | McManus Kevin Chief Human Resources Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-28 6:38 pm | N/A 2032-10-26 | Omega Therapeutics Inc. | OMGA | Moore Yan Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-28 6:36 pm | N/A 2032-10-26 | Omega Therapeutics Inc. | OMGA | Reed Joshua Chief Financial Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-01 4:27 pm | N/A 2032-08-30 | Omega Therapeutics Inc. | OMGA | Boehm Rainer J. Director | 36,713 | $0 | 36,713 (Direct) | View |